Recent Finacing
Recent Raise
Delfi Diagnostics develops blood-based liquid-biopsy tests that analyze genome-wide cell-free DNA fragmentomics with machine learning to detect and localize cancers and support single-cancer, multi-cancer, and monitoring applications.
